
Sign up to save your podcasts
Or
Introducing Leading Through Setbacks with Cytokinetics’ Robert Blum from Clinical Trialblazers.
Follow the show: Clinical Trialblazers
In this episode of Clinical Trial Blazers, host Alberto Grignolo speaks with Robert Blum, president and CEO of Cytokinetics, about his journey from the biology classroom to leading a biopharmaceutical company focused on muscle biology. Robert shares the values that guide his leadership style and how to move forward after failing.
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
4.8
2020 ratings
Introducing Leading Through Setbacks with Cytokinetics’ Robert Blum from Clinical Trialblazers.
Follow the show: Clinical Trialblazers
In this episode of Clinical Trial Blazers, host Alberto Grignolo speaks with Robert Blum, president and CEO of Cytokinetics, about his journey from the biology classroom to leading a biopharmaceutical company focused on muscle biology. Robert shares the values that guide his leadership style and how to move forward after failing.
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
381 Listeners
253 Listeners
192 Listeners
1,886 Listeners
415 Listeners
252 Listeners
904 Listeners
38 Listeners
1,008 Listeners
13 Listeners
41 Listeners
42 Listeners
671 Listeners
335 Listeners
36 Listeners
7 Listeners
12 Listeners
26 Listeners
12 Listeners
4 Listeners
4 Listeners
23 Listeners
25 Listeners
7 Listeners
189 Listeners
6 Listeners
161 Listeners
412 Listeners
14 Listeners
28 Listeners
9 Listeners
35 Listeners
5 Listeners